Regulatory Updates
🌏 NMPA Page 6NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 61–72 of 87 articles
Clinical Trials Day 2026: Research Rising in Oncology
Ildong Pharmaceutical Stock: Earnings and Pipeline Insights
Kelun and Merck's Lung Cancer Combo Shows Promise in China
Kelun-Biotech Secures Investigational New Drug Approval for SKB118
Merck’s Billion-Dollar Bet on TROP2: Regulatory Updates and Implications
Novartis Strengthens Prostate Cancer Treatment with Pluvicto
ZTE Partners with China's National Clinical Research Center for Clinical Trials
Asia-Pacific Regulatory Updates: TGA Guidance on Compounded Medicines
Asia Bacitracin Ointment Market Analysis and Regulatory Updates
India's CDSCO Adopts Prior Intimation System for Clinical Trials
The Week in Pharma: Action, Reaction, and Insight – May 15, 2026
Rusan Pharma Secures GMP Clearance from Japan's PMDA